230
Participants
Start Date
September 2, 2021
Primary Completion Date
February 11, 2022
Study Completion Date
February 11, 2022
Pilocarpine HCl
Pilocarpine HCl ophthalmic solution 1.25% ocular drops.
Vehicle
Oxymetazoline HCl and pilocarpine HCl placebo ocular drops.
Nature Coast Clinical Research - Crystal River /ID# 231298, Crystal River
Advancing Vision Research /ID# 231244, Smyrna
Eye associates /ID# 231262, San Antonio
United Medical Research Institute /ID# 233982, Inglewood
Empire Eye and Laser /ID# 231433, Bakersfield
Global Research Management /ID# 231300, Glendale
North Valley Eye Medical Group, Inc. /ID# 231270, Mission Hills
The Eye Research Foundation /ID# 231274, Newport Beach
Martel Eye Medical Group /ID# 231332, Rancho Cordova
Bruce Segal, MD /ID# 231413, Delray Beach
Clayton Eye Clinical Research, LLC /ID# 231243, Morrow
Jacksoneye, SC /ID# 231374, Lake Villa
Price Vision Group /ID# 231261, Indianapolis
Kannarr Eye Care /ID# 231363, Pittsburg
Cincinnati Eye Institute- Edgewood /ID# 231356, Edgewood
The Eye Care Institute /ID# 231275, Louisville
Rochester Ophthalmological Group PC /ID# 231371, Rochester
Southern College of Optometry /ID# 231325, Memphis
Total Eye Care, PA /ID# 231245, Memphis
Hill Country Eye Center /ID# 231293, Cedar Park
The Cataract & Glaucoma Center /ID# 231292, El Paso
Hoopes, Durrie, Rivera Research /ID# 231273, Draper
Country Hills Eye Center /ID# 231414, Ogden
Lead Sponsor
Allergan
INDUSTRY